Opioid detox for Lake Worth Beach — fentanyl-era protocols, buprenorphine done right.

For Lake Worth Beach clients — 14 miles and 22 minutes down I-95 — RECO Island runs COWS-guided, buprenorphine-forward opioid detox with same-team transition into residential care under one roof. Fentanyl-era induction: micro-induction where indicated, comfort medications by nursing round, and the MAT decision (buprenorphine, methadone referral, or extended-release naltrexone) settled before discharge. Naloxone education and a Narcan prescription are standard on the way out.

Lake Worth Beach sits 14 miles up A1A from RECO Island’s Delray Beach campus — roughly a 22-minute drive down I-95 in normal conditions, longer during season when Ocean Boulevard thickens through Palm Beach. For clients from Bryant Park, College Park, Mango Groves, Parrot Cove, and downtown Lake Worth, that proximity means opioid detox and residential treatment without leaving the county and without the third-party handoffs that fracture continuity of care.

Opioid withdrawal in the fentanyl era

Fentanyl has changed opioid withdrawal management materially. Its potency (roughly 100 times morphine), unpredictable pharmacokinetics, and near-universal adulteration of the street opioid supply produce a withdrawal syndrome that emerges faster, hits harder, and behaves less predictably than heroin or prescription opioid withdrawal.

The clinical implications are concrete. Traditional buprenorphine induction — historically initiated at 12 to 24 hours of moderate withdrawal (COWS 11 or higher) — carries elevated risk of precipitated withdrawal in fentanyl-exposed patients because of fentanyl’s lipophilicity and prolonged tissue release. Micro-induction protocols starting at 0.5 mg and titrated across several days while residual fentanyl clears, or extended pre-induction intervals of 36 to 72 hours, are now common practice in addiction medicine.

RECO Island’s opioid detox protocol reflects current practice, not the pre-fentanyl playbook. Physicians assess time since last use, urine toxicology (including specific fentanyl and xylazine assays), and clinical presentation before choosing an induction strategy. Treating that decision as one-size-fits-all is how precipitated withdrawal happens.

COWS-guided buprenorphine induction

The Clinical Opiate Withdrawal Scale (COWS) is the objective backbone of induction timing. Eleven symptom domains are scored: resting pulse rate, sweating, restlessness, pupil size, bone and joint aches, runny nose or tearing, GI upset, tremor, yawning, anxiety or irritability, and gooseflesh skin. Scores of 5 to 12 indicate mild withdrawal; 13 to 24 moderate; 25 to 36 moderately severe; over 36 severe.

Standard induction begins at COWS 11 with 2 to 4 mg of sublingual buprenorphine, with additional 2 to 4 mg doses every 1 to 2 hours as needed, titrating toward a first-day total of 8 to 16 mg. Maintenance dosing is typically 8 to 24 mg daily depending on cravings, breakthrough withdrawal, and pharmacokinetics. For fentanyl-exposed patients, low-dose induction starting at 0.5 mg may be indicated to bridge safely.

Comfort medications supplement induction rather than replacing it. Clonidine addresses autonomic hyperactivity — sweats, hypertension, tachycardia. Loperamide controls diarrhea. Ondansetron handles nausea. Cyclobenzaprine or methocarbamol addresses muscle cramping. Hydroxyzine or gabapentin support sleep and anxiety without benzodiazepine risk. Nursing rounds every 2 to 4 hours with re-scoring govern the acute phase.

Buprenorphine, methadone, or naltrexone: the MAT decision

Three FDA-approved medications have strong evidence for opioid use disorder maintenance, and the decision among them is clinical, not ideological. Buprenorphine (Suboxone, Subutex, Sublocade) is a partial mu-agonist with a ceiling effect that limits overdose risk; it is office-based and appropriate for most clients. Methadone is a full agonist with more potent craving suppression but requires daily attendance at a federally licensed opioid treatment program — a logistical reality Lake Worth Beach clients need to weigh.

Extended-release naltrexone (Vivitrol) is a mu-antagonist delivered as a monthly intramuscular injection. It requires a 7 to 10 day opioid-free period before initiation to avoid precipitated withdrawal — precisely what a supervised detox stay enables. Naltrexone is often preferred by clients who want a non-opioid maintenance option, and by those in professions with monitoring boards that discourage agonist therapy.

The decision is made with the client during the detox stay, weighing prior MAT response, comorbid conditions, employment, and treatment access at discharge. The prescription — whether a buprenorphine taper, a Sublocade injection, a maintenance script, or Vivitrol induction — is set up before the client leaves the acute unit for residential care.

Naloxone education and the post-detox safety net

Overdose mortality risk is highest in the four weeks immediately following detox. Opioid tolerance drops precipitously during any abstinent period, and any return to prior-use quantities — even a fraction of them — can be fatal, particularly in the fentanyl-adulterated supply that dominates South Florida. This is not hypothetical; it is the leading cause of post-detox death, and it is addressable.

Every RECO Island opioid detox client and at least one family member or support person receives naloxone (Narcan) training and a prescription before discharge. Training covers overdose recognition (blue lips, pinpoint pupils, unresponsiveness, agonal breathing), administration (intranasal 4 mg, repeat every 2 to 3 minutes), rescue breathing, and 911 activation. Take-home kits include two doses because fentanyl overdoses frequently require multiple administrations.

Naloxone distribution, MAT continuation, and harm reduction counseling are the interventions with the strongest evidence for reducing post-detox overdose mortality. Any program that discharges without them is out of step with the medical standard of care.

What the first 24 hours look like

Admission from Lake Worth Beach typically begins with a phone call to admissions and a same-day intake window. Intake includes a physician-led medical history and physical, psychiatric screening with PHQ-9 for depression and GAD-7 for anxiety, and an ASAM Criteria multidimensional assessment across the six dimensions — acute intoxication and withdrawal, biomedical, emotional and behavioral, readiness to change, relapse potential, and recovery environment.

Toxicology screening captures current exposure — heroin, fentanyl, xylazine, methamphetamine, benzodiazepines, alcohol — because polysubstance use is the rule, not the exception. Clients arriving in active withdrawal are stabilized with comfort medications while induction timing is calibrated. Clients arriving before withdrawal onset are monitored on the unit until COWS crosses the induction threshold.

Concurrent psychiatric care begins on day one. Depression, PTSD, and anxiety frequently co-occur with opioid use disorder; sertraline, mirtazapine, or non-habit-forming sleep support may be initiated by the addiction psychiatrist during the detox stay. Trauma-focused therapies (EMDR, cognitive processing therapy) and skills work (CBT, DBT, ACT, motivational interviewing) are queued for the residential phase, which begins in-house without transfer.

Insurance and the drive from Lake Worth Beach

RECO Island is in-network with the major commercial insurers Lake Worth Beach residents most commonly carry: Florida Blue, BCBS, Aetna, Cigna, UnitedHealthcare, and Humana. Verification of benefits is same-day; admissions runs the plan through utilization review, confirms the level of care authorized (ASAM 3.7 medically monitored detox and 3.5 residential), and communicates any patient responsibility before intake.

The drive from Lake Worth Beach to Delray Beach is 14 miles — roughly 22 minutes down I-95, longer during season when Ocean Boulevard traffic thickens through Palm Beach and Boynton. Family transport is common, admissions offers ride coordination when transport is a barrier, and the proximity makes weekly family therapy realistic during the residential phase.

Because detox and residential are the same census and the same clinical team, the transition from acute withdrawal into residential care is direct — no discharge paperwork, no re-intake, no gap where medication access, therapeutic relationships, or motivation lapse. That continuity is the single most concrete argument for a program that runs both under one roof.

Serving residents of: Bryant Park, College Park, Mango Groves, Parrot Cove, downtown Lake Worth.